A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD

BACKGROUND: NS2359 is a potent reuptake blocker of noradrenalin, dopamine, and serotonin. The aim of the study was to investigate the efficacy, safety and cognitive function of NS2359 in adults with a DSM IV diagnosis of ADHD. METHODS: The study was a multi-centre, double-blind, randomized placebo-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilens, Timothy E, Klint, Thorsten, Adler, Lenard, West, Scott, Wesnes, Keith, Graff, Ole, Mikkelsen, Birgit
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442604/
https://www.ncbi.nlm.nih.gov/pubmed/18554401
http://dx.doi.org/10.1186/1744-9081-4-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442604/
https://www.ncbi.nlm.nih.gov/pubmed/18554401
http://dx.doi.org/10.1186/1744-9081-4-24

Ejemplares similares